Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,293 | 9,555 | 8,407 | 7,106 | 5,816 |
| Receivables | 18,454 | 21,444 | 20,486 | 19,453 | 16,010 |
| Inventories | 20,158 | 14,165 | 13,831 | 12,931 | 14,325 |
| TOTAL | $48,050 | $45,294 | $43,161 | $40,014 | $37,157 |
| Non-Current Assets | |||||
| PPE Net | 9,864 | 10,177 | 10,571 | 10,175 | 10,095 |
| Intangibles | 7,241 | 7,241 | 7,241 | 6,341 | 6,341 |
| Other Non-Current Assets | 25,602 | 25,486 | 26,873 | 27,123 | 21,104 |
| TOTAL | $42,707 | $42,904 | $44,686 | $43,639 | $37,540 |
| Total Assets | $90,757 | $88,198 | $87,846 | $83,654 | $74,696 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,290 | 4,368 | 4,430 | 4,296 | 4,306 |
| Accounts payable and accrued liabilities | 5,840 | 1,983 | 2,607 | 2,714 | 2,891 |
| Accrued Expenses | 3,719 | 5,704 | 6,228 | 5,302 | 11,885 |
| TOTAL | $14,689 | $12,854 | $14,015 | $13,050 | $19,159 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,052 | 3,076 | 3,245 | 3,280 | 3,317 |
| Deferred Revenues | 9 | 12 | 13 | 13 | 13 |
| Other Non-Current Liabilities | 35,242 | 23,577 | 10,932 | 8,255 | 5,597 |
| TOTAL | $39,622 | $28,077 | $15,581 | $13,021 | $9,124 |
| Total Liabilities | $54,311 | $40,931 | $29,595 | $26,071 | $28,283 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,068,273 | 1,068,273 | 1,068,273 | 1,068,273 | 1,017,781 |
| Common Shares | 1,068 | 1,068 | 1,068 | 1,068 | 1,018 |
| Retained earnings | -137,702 | -126,810 | -115,774 | -116,389 | -119,715 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $36,446 | $47,267 | $58,251 | $57,583 | $46,414 |
| Total Liabilities And Equity | $90,757 | $88,198 | $87,846 | $83,654 | $74,696 |